Immtech Pharmaceuticals, Inc.

Board Members

Eric L. Sorkin
Chairman and Chief Executive Officer

Mr. Sorkin has 25 years of making strategic investments and business development. He has been
affiliated with Immtech since 1998, when he became an investor. In 2000, Mr. Sorkin became a
director for the Company, and more recently was appointed Chairman of the Board and CEO.
Mr. Sorkin began his career on Wall Street in 1982 working at Dean Witter, which is now a subsidiary
of Morgan Stanley, and from an entry-level position, he was promoted to Managing Director within
six years. He was among the core group of professionals at the firm, which developed the firm’s
investment portfolio with assets of over USD $3 billion. Mr. Sorkin was responsible for investment
selection, negotiations, transaction and financial structuring, debt placement, and asset management.
Mr. Sorkin was Officer of over 20 public investment partnerships with investment funds totaling over
USD $1 billion. In 1993, Mr. Sorkin created his own investment firm and began making private equity
investments in the U.S. and in China. Mr. Sorkin graduated from Yale University with a B.A. in Economics.

Cecilia Chan
Vice Chairman
- BIO

David Fleet
Principal, David Fleet Pharmaceutical Industry Consultancy Services
Non-Executive Director, OnMedica Group Ltd.
Director, IatRx Pharma Ltd.
- BIO

Judy Lau
Chairperson, Convergent Business Group
Hong Kong, PRC
- BIO

Levi Hong Kaye Lee, M.D.
Queen Mary Hospital
Hong Kong, PRC
- BIO

Donald F. Sinex
Board Director
Devonwood, Inc.
- BIO

Advisor

Dr. Dorothy S. Zinberg
Center for Science and International Affairs
Kennedy School of Government
Harvard University
- BIO